Validation of non-invasive measurement of zinc protoporphyrin for detection of iron deficiency in pregnancy.
In addition, the impact of iron deficiency on the incidence of postpartum depression, restless legs syndrome, obstetric complications and quality of life will be examined.
any timepoint during or up to 3 months after pregnancy
age ≥ 18 years
written informed consent
previous participation in this study
refusal of blood sampling
incapacity to give informed consent
pregnant women ≥ 18 years
Cohort
Prospective
non-invasive measurement of zink protoporphyrin
Diagnostic testvalidation of non-invasive measurement of zink protoporphyrin
Accuracy of non-invasive zinc protoporphyrin for the detection of iron deficiency in pregnancy
To validate accuracy of non-invasively measured ZnPP for detection of iron deficiency in pregnancy at prespecified timepoints
Influence of iron status on quality of life of pregnant women
To evaluate whether iron deficiency has an impact on the risk of impaired quality of life in pregnancy. Questionnaire: Short Form 12 (SF-12)
Influence of iron status on incidence of postpartum depression
To evaluate whether iron deficiency has an impact on the risk of postpartum depression. Questionnaire: Edinburgh Postnatal Depression Scala (EPDS)
Influence of iron status on incidence of restless legs syndrome among pregnant women
To evaluate whether iron deficiency has an impact on the risk of restless legs syndrome in pregnancy. Questionnaire: International Restless Legs Scale (IRLS)
Influence of iron status on incidence of preterm birth
To evaluate whether iron deficiency has an impact on the risk of preterm delivery
Click on the lead sponsor to view all of their trials.
